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Background: In contrast with the recommendations of clinical practice guidelines, the most common treatment for
anxiety and depressive disorders in primary care is pharmacological. The aim of this study is to assess the efficacy of
a cognitive-behavioural psychological intervention, delivered by primary care psychologists in patients with mixed
anxiety-depressive disorder compared to usual care.
Methods/Design: This is an open-label, multicentre, randomized, and controlled study with two parallel groups. A
random sample of 246 patients will be recruited with mild-to-moderate mixed anxiety-depressive disorder, from the
target population on the lists of 41 primary care doctors. Patients will be randomly assigned to the intervention
group, who will receive standardised cognitive-behavioural therapy delivered by psychologists together with usual
care, or to a control group, who will receive usual care alone.
The cognitive-behavioural therapy intervention is composed of eight individual 60-minute face-to face sessions
conducted in eight consecutive weeks. A follow-up session will be conducted over the telephone, for reinforcement
or referral as appropriate, 6 months after the intervention, as required.
The primary outcome variable will be the change in scores on the Short Form-36 General Health Survey. We will
also measure the change in the frequency and intensity of anxiety symptoms (State-Trait Anxiety Inventory) and
depression (Beck Depression Inventory) at baseline, and 3, 6 and 12 months later. Additionally, we will collect
information on the use of drugs and health care services.
Discussion: The aim of this study is to assess the efficacy of a primary care-based cognitive-behavioural psychological
intervention in patients with mixed anxiety-depressive disorder. The international scientific evidence has demonstrated
the need for psychologists in primary care. However, given the differences between health policies and health services,
it is important to test the effect of these psychological interventions in our geographical setting.
Trial registration: NCT01907035 (July 22, 2013).
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The prevalence of mental disorders in primary care (PC)
in Europe is around 20-55% [1-3]. In association with
the current economic crisis, there has been an alarming
increase of PC consultations for psychological distress
[4,5]. It has been estimated that a quarter of patients
who attend PC consultations have had a mental disorder
in the previous year, in particular problems related to
anxiety and/or depression [1,2,6,7]. In our multi-tiered
public health system, around 85-90% of these patients
are treated in PC settings [8].
Among mood disorders, the coexistence of anxiety
and depression is the norm rather than the exception
[9]. Specifically, adjustment disorders are very common,
that is, signs and symptoms of mixed anxiety/depression
in the context of changing situations that force people to
adjust to new situations [1,10].
Clinical practice guidelines recommend cognitive-be-
havioural therapy (CBT) as the treatment of choice for
affective and mood disorders. The use of psychoactive
drugs is only recommended for the most severe cases
and always in combination with psychological treat-
ment [11-14]. However, the real adherence to these
evidence-based clinical guidelines is very poor in gen-
eral, and several studies have shown that in PC psycho-
active drugs are more widely used than psychological
techniques, [15]. In relation of this, the Strategy for
Mental Health of the Spanish National Health Service
recognised that that there has been a significant
medicalization of everyday life and that there is a ten-
dency towards an overuse of pharmacological ap-
proaches, these requiring less time, as well as less
professional expertise and involvement, for the treat-
ment of disorders that should be addressed with spe-
cific psychological interventions [16].
There is strong evidence that the efficacy of psycho-
logical therapy and CBT in particular, is the same as or
greater than pharmacological treatments of the most
common affective and anxiety disorders, as well as it
having greater long-term effectiveness [17-19]. Notably,
the benefits of psychological approaches include a reduc-
tion in symptoms associated with anxiety and depres-
sion, a decrease in the risk of relapses, the stability of
the effect of the treatment in the long term, and high
rates of recovery, preventing the condition becoming
chronic and decreasing healthcare costs, in terms of
medical consultations and use of drugs, as well as sick
leave [20-22]. Various studies have suggested that the
introduction of psychological interventions in primary
care may significantly reduce healthcare and social costs
related to mental disorders [23,24]. Specifically, although
the cost of psychological treatments may seem high due
to the need for trained psychologists, psychological in-
terventions, and CBT in particular, have been found tobe more cost-effective in the long term compared to the
cumulative costs of the use of antidepressants [25].
The introduction of this type of therapy in routine pri-
mary care practice may not be feasible due to, among
other reasons, the limited time available per consultation.
Some authors have suggested that the role of non-
specialist psychologist (although trained in health psych-
ology) should be included in primary care services [26,27].
The objective of this study is to assess the efficacy of
CBT-based psychological interventions delivered by pri-
mary care psychologists in patients with mixed anxiety-
depressive disorder.Aims of the study
The primary objective of this study is to assess the efficacy
of a CBT-based psychological intervention delivered by
psychologists in collaboration with general practitioners
(GPs) in primary care settings in patients with mild-to-
moderate mixed anxiety-depressive disorder, in terms of
perceived quality of life and general health, compared to
usual care, provided by GPs.
The secondary objectives are to assess the effect of the
CBT-based psychological intervention on the level of
anxiety and depressive symptoms, healthcare costs in
terms of consumption of psychoactive drugs and use of
healthcare resources, and the sick leave taken (number
of times and the length of absence), compared to usual
care. Additionally, our aim is also to assess the level of
satisfaction of doctors and patients in both groups re-
garding the treatment administered, twelve months after
the beginning of the intervention.Study hypotheses
The main working hypothesis is that the CBT delivered
by psychologists will be more effective than the usual
care provided by primary care doctors, in terms of an
improvement by at least 10 points on the Short Form-36
General Health Survey (SF-36) in the mid (6 months)
and long (12 months) term in patients with mixed
anxiety-depressive disorder.
Additionally, the intervention will be more effective than
usual care in the reduction of anxiety and depressive
symptoms, as assessed by the State-Trait Anxiety Inven-
tory (STAI) and the Beck Depression Inventory (BDI),
respectively.
Further, we expect to observe a greater reduction in
healthcare costs in terms of consumption of psychoactive
drugs and use of healthcare resources as well as in the
number and length of sick leave absences in the interven-
tion group than in the control group.
Finally, we also expect GPs and patients to be more sat-
isfied with the intervention than the control treatment.
ELIGIBLE PATIENTS  
Users (18-75 years old) of the participating health 
centres diagnosed with mixed anxiety-depressive 
disorder  
Goldberg's Depression and Anxiety Scales 
Identification of cut off points  
Anxiety ≥ 4 and Depression ≥ 3 
Patients 
excluded 
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Design of the trial
This will be an open-label parallel-group randomised con-
trolled trial. Eligible patients will be randomly assigned to
one of the study groups: the intervention group (IG), re-
ceiving a CBT-based psychological treatment together
with usual care, or the control Group (CG) receiving usual
care provided by GPs. The principal outcome measure will
be the change in quality of life in patients with mixed
anxiety-depressive disorder, assessed at four times points:
at baseline, that is, pre-treatment; and at 3, 6 and 12
months after the initial assessment.Random selection of 246 patients 







A total of 41 GPs of 7 primary care health centres will
participate in the study. The psychologists in charge of
delivering the psychological therapy are staff of the
Basque Health Service. Patient assessments will be per-
formed by a researcher contracted for the purpose with
specific training for taking the required measurements.
The health centres have the necessary infrastructure
and resources to carry out the measurements and the
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N=123
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Figure 1 Flow chart of patient recruitment and randomisation.Participants and recruitment process
Eligible subjects will be: patients of the participating health
centres, over 18 years of age, who have been diagnosed by
their GP with mild-to-moderate mixed anxiety-depressive
disorder, and obtained scores of at least 4 on the anxiety
subscale and at least 3 on the depression subscale of the
Goldberg Anxiety and Depression Scale (GADS) [28,29]
(see Figure 1 for an overview). We will apply the following
exclusion criteria: being over 75 years old; not being able
to understand and/or speak Spanish; or having cognitive
impairment that could interfere with assessments or inter-
vention; a serious disease or medical condition that could
result in death in the following 12 months or a high prob-
ability of loss to follow up; or a psychotic or other severe
mental illness, as well as a history of suicide attempts or
persistent suicidal ideation. Patients who referred to spe-
cialised care and any under psychological treatment in the
private sector will also be excluded.
The study will be presented to the GPs of the partici-
pating centres. Among those interested in participating
in the study, we will randomly select (using a computer
program) a sample of 41 GPs balanced by health centre.
Each participating GP will be given a list of patients
based on the search criterion “active mixed anxiety-
depressive disorder”. From each list of eligible patients, a
sample of six patients we be randomly selected to be
given an appointment at which their GP will explain the
details of the study and check that patient meets the in-
clusion criteria. If they do, the patient will be formallyinvited to participate, giving them a copy of the patient
information leaflet and informed consent form.
Once they have signed the informed consent form,
participating patients will be randomly assigned to the
IG or the CG following a simple randomisation with a
1:1 allocation ratio using the EpiData 4.0 computer pro-
gram, with the interviewer and the person in charge of
data analysis being blind to group allocation at all times.
Materials
GPs will use the Spanish version of GADS [28,29] for
screening their samples of patients. This scale consists on
a short interview questionnaire that has been shown to be
useful in the identification of likely cases of anxiety and
depression. It has good psychometric properties, with a
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least 4 on the anxiety subscale and of at least 3 on the
depression subscale have been established as an inclu-
sion criterion.
An assessor trained for the purpose, contracted for the
project and blind to patient group allocation, will carry
out assessments at four time points over course of the
study: baseline (pre-treatment) and 3, 6, and 12 months
after the intervention. To assess the level of depression,
we will use the BDI [30] validated for the Spanish popu-
lation by Sanz et al. [31]. The BDI has acceptable psy-
chometric properties as an assessment instrument for
measuring depressive symptoms in adults, and is the
most widely used questionnaire for assessing the re-
sponse to treatment of patients with depression.
As for assessing the level of anxiety, we will use the
Spanish version of the STAI [32,33]. The STAI is a self-
administered questionnaire composed of 40 items rated
on a 4-point Likert scale. It assesses two independent
types of anxiety: anxiety as a trait (A/T), which refers to
relatively permanent and stable dimension of personality
or a tendency towards reacting anxiously; and anxiety as a
state (A/S), which detects behaviours associated with tran-
sient situational anxiety, present during the assessment.
For assessing health-related quality of life and general
status, we will use the Spanish version of the SF-36
[34,35]. It is composed of 36 items rated on Likert scales
and refers to various aspects of health divided into 8 di-
mensions (physical functioning, role-physical, bodily pain,
general health, vitality, social functioning, role-emotional
and mental health). In addition, two global subscores can
be calculated that represent the physical and mental state
of health: the physical component summary (PCS) and
the mental component summary (MCS). All the raw
scores of the SF-36 are normalised and transformed to a
scale from a 0 to 100, with higher scores indicating better
general health status and self-perceived quality of life.
Additionally, at the first (baseline) and the last (12
months) assessments, patients will complete the Health
Resource Use Questionnaire, prepared ad hoc to collect
data on the use of healthcare resources in the previous
weeks, as well as the use of drugs and medical consulta-
tions, among other factors. Finally, in the last assessment
(12 months), all the patients and GPs participating in
the study will be asked about their level of satisfaction
with the treatment provided, rating it on a visual
analogue scale (VAS) ranging from 0 to 10.
Intervention
Patients assigned to the CG will be treated by their GP
and will receive the usual care. Patients assigned to the
IG will be contacted by telephone by the psychologist to
make a first appointment and plan the subsequent ses-
sions. The design of the intervention is based on CBTprogrammes for groups developed by local experts in
the field [36,37]. The research team has updated these
programmes and adapted them for use with individuals,
with additional information technology support and giv-
ing a more active role to patients.
The intervention consists of 8 individual 60-minute
face-to-face sessions, to be carried out during 8 consecu-
tive weeks in the health centres. Six months after the
start of the intervention, at the same time as the third
measurement, there will be a follow-up session over the
telephone, for reinforcement or referral, as appropriate.
Each of the sessions has specific objectives and is fo-
cused on various areas:
– 1st session: Psychoeducational explanation of the
nature and characteristics of mixed anxiety-
depressive disorder. Contextualisation of the inter-
vention. Provision of a copy of the patient
handbook.
– 2nd session: Establishment of a programme of
rewarding or reinforcing factors based on carrying
out regular enjoyable activities, to be recorded by
patients in their handbook. Training in relaxation
and controlled breathing. Sleep hygiene advice.
– 3rd session: Tackling the symptoms of anxiety.
Construction of a hierarchy of feared situations,
counselling on exposure to stress factors or feared
situations.
– 4th session: Learning and developing techniques
focused on detecting and blocking automatic
negative thoughts
– 5th session: Learning and developing techniques
focused on restructuring automatic negative
thoughts
– 6th session: Role playing. Work on situations that
perceived as difficult. Learning strategies for
problem solving. Self-instruction and self-control.
– 7th session: Developing social skills. Assertiveness
and self-concept.
– 8th session: Assessment and end of the intervention.
Implementation of strategies to prevent relapses.
– Follow-up session. Telephone consultation lasting
for 15 minutes, 6 months after starting the
intervention. Identification of high-risk cases; moni-
toring, reinforcement or referral, as appropriate.
As well as this CBT-based intervention, patients
assigned to the IG will also be treated by their GP with
the usual care.
Adverse effects
There is no evidence concerning the potential adverse ef-
fects of the CBT-based psychological intervention. How-
ever, during the intervention, the psychologist and GP will
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regardless of whether there is a causal relationship with
the intervention. All the adverse effects will be recorded
in a database created for the purpose, stating their severity
and causal association with the treatment. Additionally,
there will be a committee, independent of the research
team that will monitor the safety of the treatment under
study and will analyse and extensively review any adverse
effects that occur during the study.
Data quality and management
We have taken various steps to ensure the quality and
reliability of the data collected in the study including:
– Creation a specific case report form, with notes on
each case
– Double data entry to minimise errors during data
storage and processing
– Preparation of documents to support health
professionals in decision making and to facilitate the
standardisation of the intervention and data
collection
Sample size
We have estimated a target sample of 246 patients, equally
divided between the IG and the CG. This sample size
would provide a statistical power above 80% for detecting
a difference between the IG and the CG of at least 10
points in the overall SF-36 score as significant (p < 0.05)
using a two-tailed Student’s t-test (standard deviation =
13.15, obtained from previous study with similar popu-
lations [1]). Similarly, this sample size would provide a
statistical power above 80% for detecting as statistically
significant a difference of at least 10 points in scores on
the following dimensions: general health, vitality and
mental health in the SF-36 health survey (SD = 22.10).
We have estimated a loss to follow-up of 10% during
the 12-month follow-up.
Statistical analyses
The statistical analysis of data will be performed on an
intention-to-treat basis, comparing the changes in the
two groups, IG and CG, in the measurements taken 3, 6
and 12 after the initial assessment. The effect attribut-
able to the intervention will be assessed by analysing the
difference in the changes between the groups, and 95%
confidence intervals will be calculated, adjusting the
values for the baseline levels, using analysis of covari-
ance (ANCOVA). As the baseline level, results will be
adjusted for covariable that could confound or modify
the effect of the intervention.
To take into account the potential effect of having pa-
tients grouped by GPs, the aforementioned ANCOVA
models will be extended to mixed-effect models thatinclude the random effect of each GP, both on the inter-
cept and the effect of the intervention.
Finally, to analyse the overall changes in health-
related quality of life over the 12 months of the study,
the effect of time on the 4 repeated measures collected
from each patient will be estimated using a longitudinal
mixed-effect model with fixed effects (intervention,
time, time-intervention interaction) and random effects
(specific effect of each subject and each doctor and
health centre).
Interactions between time and the specific effect of
subjects, GPs and health centres will also be explored.
Data analysis will be performed using the statistical
package SAS for Windows.
Legal and ethical considerations
This study complies with the Declaration of Helsinki
and its subsequent reviews, as well as with the Good
Clinical Practice guidelines. We have taken measures for
safeguarding the confidentiality of the information col-
lected. Only the researchers participating in the study
will have access to the data related to patients.
The present project has been approved by the Clinical
Research Ethics Committee of the Basque Country
(CEIC-E). In addition, the legal representative of each
health centre has signed a document stating that they
understand the study and are committed to collaborate
with the services involved.Limitations
Patients will be selected retrospectively based on their
medical diagnosis, and hence patients with mixed
anxiety-depressive disorder who have not been given this
diagnosis or whose diagnosis has not been coded in their
medical record will not be included in this study, affect-
ing the external validity of the study.
The assessor and initially the GPs will be blind to
group allocation. However, in our design, it is not pos-
sible for patients to be masked to treatment, and there-
fore we are not able control the interaction between
patients and GPs.
This study has also a feasibility issue, given that it at-
tempts to explore changes in patients after an intervention
delivered by health professionals who are not currently
present in primary care, that is, psychologists. Hence, it is
possible that we will fail to recruit the number of psychol-
ogists required to work with the sample of patients.
Discussion
The prevalence rates of mental health conditions and in
particular, anxiety and depression have shown an upward
trend in recent years, probably exacerbated by the current
economic situation and high rates of employment in our
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Health Survey, it is estimated that around 15% of the adult
population has some type of mood disorder related to
anxiety and depression [39], a much high percentage than
in previous years. Since 2006, we have observed significant
growth in the percentage of patients seeking medical as-
sistance for psychological problems [4]. Further, the im-
pact of mental disorders on quality of life and general
health is even greater than that of other chronic disorders,
such as arthritis, diabetes, cardiovascular or respiratory
diseases [40], and is often associated with a significant in-
crease in the use of healthcare resources [41,42]. Mental
health conditions account for approximately 20% of health
expenditure in developed countries, and this percentage is
expected to rise in the near future.
According to the World Health Organisation, des-
pite the resources dedicated to mental healthcare in
terms of prescriptions of psychoactive drugs, medical
consultations, and emergency services, as well as the
costs of related work absenteeism and sick leave, most
patients with mental health problems do not receive
the best treatment for their condition [40]. The key
evidence-based clinical practice guidelines recommend
CBT-based psychological interventions for treating
mild-to-moderate, subclinical mood disorders, and
recommend against routinely prescribing anxiolytics
and antidepressants [12,13].
Most research on the effectiveness of CBT for the
treatment of emotional disorders has focused on specia-
lised mental care. However, in our health service, most
patients with non-severe mood disorders are treated in
primary care and are not referred to mental health spe-
cialists [41]. In general, patients themselves prefer to be
treated in the primary care setting, it been more access-
ible and less stigmatised than mental health services
[43]. However, the treatment of psychological problems
in primary care is currently still over-medicalised, based
on a traditional biomedical model, in which the prescrip-
tion of antidepressants is the treatment of choice in
most cases. In this context, the introduction of psycho-
logical care services in primary care seem a necessary
step towards a biopsychosocial model, in which mental
health problems are tackled in an integrated way.
There have been some attempts to train primary care
health professionals, in particular doctors and nurses, in
psychological counselling techniques for addressing the
problems related to the management of stress, anxiety
and depression. However, this type of training does not
seem to result in benefits over the usual care provided in
primary care [44]. It seems clear that the most suitable
professionals to carry out CBT interventions are psy-
chologists, who have a specific training in the diagnosis
and treatment of mental health conditions and could
work at the primary care level.The aim of this clinical trial is to assess the efficacy of a
CBT-based psychological intervention, delivered by psy-
chologists at the PC level, in patients with mixed anxiety-
depressive disorder, compared to the usual care provided
by their GPs. Although some studies in other places have
provided promising results, differences in health policies
and public health systems between countries make it ne-
cessary to assess the effectiveness of psychological inter-
ventions in our geographical setting. We also want to
evaluate their potential effect on the reductions in health
expenditure in terms of consumption of psychoactive
drugs, medical consultations, and emergency department
attendances, as well as in work absenteeism and sick leave.
If the results of this study were to be in line with the
expectations of the research team, health authorities
should roll out this type of intervention. This would in-
volve an organisational and structural change at very
timely moment in the current process of integration be-
tween PC and specialised care in our health care system.
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